Literature DB >> 1679189

Effect of dietary alpha-linolenate/linoleate balance on endotoxin-induced hepatitis in mice.

S Watanabe1, H Okuyama.   

Abstract

Mice were fed diets with three different ratios of alpha-linolenate (18:3n-3) to linoleate (18:2n-6), and the severity of hepatitis during endotoxic shock was compared. Dietary enrichment with alpha-linolenate increased the severity of hepatitis and the mortality induced by lipopolysaccharide (LPS) in combination with D-galactosamine (GalN). Differences in the dietary alpha-linolenate/linoleate balance were mainly reflected in the levels of arachidonate and eicosapenatenoate in liver phospholipids. Pretreatment of mice with indomethacin was found to also enhance the severity of GalN/LPS-hepatitis. This indicated that cyclooxygenase products of arachidonate may suppress the development of GalN/LPS-hepatitis. The enhancement by high alpha-linolenate diets was not observed when a lethal dose of LPS in the absence of GalN was given. Our results indicate that there are pathophysiological conditions of endotoxin-induced hepatitis under which cyclooxygenase products of arachidonate play protective roles.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679189     DOI: 10.1007/bf02536074

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  34 in total

1.  Effect of dietary alpha-linolenate/linoleate balance on lipopolysaccharide-induced tumor necrosis factor production in mouse macrophages.

Authors:  S Watanabe; H Hayashi; K Onozaki; H Okuyama
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

2.  Pulmonary removal of circulating endotoxin results in acute lung injury in sheep.

Authors:  A E Warner; M M DeCamp; R M Molina; J D Brain
Journal:  Lab Invest       Date:  1988-08       Impact factor: 5.662

3.  Effects of moderate dietary supplementations with n-3 fatty acids on macrophage and lymphocyte phospholipids and macrophage eicosanoid synthesis in the rat.

Authors:  C Brouard; M Pascaud
Journal:  Biochim Biophys Acta       Date:  1990-10-22

4.  Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Autoregulatory role of leukotriene B4.

Authors:  C M Dubois; E Bissonnette; M Rola-Pleszczynski
Journal:  Am Rev Respir Dis       Date:  1989-05

5.  Stimulation of anaphylaxis in the mouse footpad by dietary fish oil fatty acids.

Authors:  S Yoshino; E F Ellis
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1989-06       Impact factor: 4.006

6.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

7.  The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants.

Authors:  K Sugino; K Dohi; K Yamada; T Kawasaki
Journal:  Surgery       Date:  1987-06       Impact factor: 3.982

8.  Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

Authors:  S L Kunkel; R C Wiggins; S W Chensue; J Larrick
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

9.  Protective effects of aspirin in endotoxic shock.

Authors:  P V Halushka; W C Wise; J A Cook
Journal:  J Pharmacol Exp Ther       Date:  1981-08       Impact factor: 4.030

10.  Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.

Authors:  V Lehmann; M A Freudenberg; C Galanos
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  1 in total

1.  Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice.

Authors:  Rozenn Mingam; Aurélie Moranis; Rose-Marie Bluthé; Véronique De Smedt-Peyrusse; Keith W Kelley; Philippe Guesnet; Monique Lavialle; Robert Dantzer; Sophie Layé
Journal:  Eur J Neurosci       Date:  2008-11       Impact factor: 3.386

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.